Corrigendum to “Validation of an assay for NGAL in a Pediatric Population” [Practical Laboratory Medicine, PLABM 486, e00486]

The authors regret that we used the wrong name of the assay. In all cases where it is referred to as Bioporto Pronephro AKI assay, we actually meant that it was the Bioporto NGAL assay since the former is only approved for Roche.

The authors would like to apologise for any inconvenience caused.